From the Stroke Clinical Research Unit, Department of Neurology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, No 37, Guo Xue Xiang, Chengdu 610041, China.
BMC Neurol. 2013 Oct 24;13:154. doi: 10.1186/1471-2377-13-154.
Few studies on whether etiologic subtype can predict outcome in mild stroke are available. The study aim to explore the effect of different etiologic subtype on prognosis of these patients.
We prospectively registered consecutive cases of acute ischemic stroke from September. 01, 2009 to August. 31, 2011. Patients with National Institute of Health Stroke Scale (NIHSS) ≦3 and within 30 days of symptom onset were included. All cause death or disability (defined as modified Rankin Scale >2) were followed up at 3 months. The multivariate logistical regression model was used to analyse relationship between etiologic subtype and clinical outcomes.
We included 680 cases, which accounted for 41.1% (680/1655) of the total registered cases. Mean age were 62.54 ± 13.51 years, and males were 65.4%. The median time of symptoms onset to admission was 72 hours. 3.8% (26/680) of cases admitted within 3 hours and 4.7% (32/680) admitted within 4.5 hours. However, no patient received intravenous thrombolysis. Of included patients, 21.5% large-artery atherosclerosis, 40.6% small-vessel disease, 7.5% cardioembolisms, 2.2% other causes and 28.2% undetermined causes. The rate of case fatality and death/disability was 2.2% and 10.1% respectively at 3 months. After adjustment of potential confounders, such as age, sex, NIHSS on admission and vascular risk factors et al., cardioembolism (RR = 3.395;95%CI 1.257 ~ 9.170) was the predictor of death or disability at 3 months and small vessel occlusion (RR = 0.412;95%CI 0.202 ~ 0.842) was the protective factor of death or disability at 3 months.
Different etiologic subtype can predict the outcome in patients with mild stroke and it can help to stratify these patients for individual decision-making.
目前关于病因亚型是否可以预测轻度卒中患者预后的研究较少。本研究旨在探讨不同病因亚型对这些患者预后的影响。
我们前瞻性登记了 2009 年 9 月 1 日至 2011 年 8 月 31 日连续发生的急性缺血性卒中患者。纳入的患者为美国国立卫生研究院卒中量表(NIHSS)评分≤3 分且症状发作后 30 天内的患者。所有患者均随访至 3 个月,观察终点为全因死亡或残疾(定义为改良 Rankin 量表评分>2 分)。采用多变量逻辑回归模型分析病因亚型与临床结局的关系。
我们共纳入 680 例患者,占登记患者总数的 41.1%(680/1655)。患者的平均年龄为 62.54±13.51 岁,男性占 65.4%。症状发作至入院的中位数时间为 72 小时。3.8%(26/680)的患者在 3 小时内入院,4.7%(32/680)的患者在 4.5 小时内入院。但是,没有患者接受静脉溶栓治疗。在纳入的患者中,大动脉粥样硬化占 21.5%,小血管疾病占 40.6%,心源性栓塞占 7.5%,其他病因占 2.2%,病因不明占 28.2%。3 个月时的病死率和死亡/残疾率分别为 2.2%和 10.1%。在校正年龄、性别、入院时 NIHSS 评分和血管危险因素等潜在混杂因素后,心源性栓塞(RR=3.395;95%CI 1.2579.170)是 3 个月时死亡或残疾的预测因素,而小血管闭塞(RR=0.412;95%CI 0.2020.842)是 3 个月时死亡或残疾的保护因素。
不同的病因亚型可以预测轻度卒中患者的预后,有助于对这些患者进行个体化决策。